semaglutide revenue Lilly's GLP-1 portfolio gains ground on Novo Nordisk Novo Nordisk developed Ozempic and

Cross-border interest from the United States The BBC reports that Ozempic costs upwards of US$1,000 per month for uninsured Americans, and that more than 15 million American adults are estimated to take GLP-1 medications [Source: bbc.com/news/articles/c142y4p2eyxo]

Additionally, significant AEs of pancreatitis acute ( n = 61, ROR 5.83, 95% CI 4.527.50), pancreatic carcinoma ( n = 49, ROR 1.73, 95% CI 1.312.30), obstructive pancreatitis ( n = 16, ROR 31.13, 95% CI 18.8151.51), and pancreatic carcinoma metastatic ( n = 12, ROR 9.95, 95% CI 5.6217.61) were also observed

Since that time Ive lost seven lbs

Semaglutide has real contraindications